首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in?vitro biological evaluation
【24h】

Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in?vitro biological evaluation

机译:基于新的苯并呋喃基磺酰胺作为选择性碳酸酐ⅠX和XII抑制剂:合成和体外生物评估

获取原文
           

摘要

Pursuing on our efforts toward searching for efficient hCA IX and hCA XII inhibitors, herein we report the design and synthesis of new sets of benzofuran-based sulphonamides (4a,b, 5a,b, 9a-c, and 10a-d), featuring the zinc anchoring benzenesulfonamide moiety linked to a benzofuran tail via a hydrazine or hydrazide linker. All the target benzofurans were examined for their inhibitory activities toward isoforms hCA I, II, IX, and XII. The target tumour-associated hCA IX and XII isoforms were efficiently inhibited with KsubI/subs spanning in ranges 10.0-97.5 and 10.1-71.8?nM, respectively. Interestingly, arylsulfonehydrazones 9 displayed the best selectivity toward hCA IX and XII over hCA I (SIs: 39.4-250.3 and 26.0-149.9, respectively), and over hCA II (SIs: 19.6-57.1 and 13.0-34.2, respectively). Furthermore, the target benzofurans were assessed for their anti-proliferative activity, according to US-NCI protocol, toward a panel of sixty cancer cell lines. Only benzofurans 5b and 10b possessed selective and moderate growth inhibitory activity toward certain cancer cell lines.
机译:在寻找高效HCA IX和HCA XII抑制剂的努力,在此报告新苯并呋喃的磺酰胺(4A,B,5A,B,9A-C和10A-D)的设计和合成的设计和合成将苯磺胺酰胺部分锚固与苯并呋喃尾尾通过肼或酰肼接头锚定。检查所有靶标苯并呋喃对同种型HCA I,II,IX和XII的抑制作用。靶肿瘤相关的HCA IX和XII同种型分别抑制了跨越跨越10.0-97.5和10.1-71.8·nm的K i 。有趣的是,芳基硫腙9展示了HCA IX和XII的最佳选择性(SIS:39.4-250.3和26.0-149.9)和HCA II(SIS:19.6-57.1和13.0-34.2)。此外,根据US-NCI方案,评估靶苯呋喃的抗增殖活性朝向六十癌细胞系的面板。只有苯并呋喃5b和10b对某些癌细胞系具有选择性和中等的生长抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号